Prolax

Quick links to important sections

Prolax

Method of action: Miorelaxant

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prolax

Quick Facts: Prolax (Chlorzoxazone)

Property Description
Active Ingredient Chlorzoxazone
Form Oral Tablet
Pharmacological Class Skeletal Muscle Relaxant
Common Use Relief of discomfort from acute muscle spasm
Origin Synthetic, Centrally Acting Agent

What Type of Medicine is Prolax and What is its Active Ingredient?

Prolax is a trade name for a prescription-only drug whose sole active ingredient is Chlorzoxazone, a synthetic compound classified as a skeletal muscle relaxant. The drug is definitively categorized as a centrally acting agent, meaning its therapeutic function stems from modulating nerve activity within the central nervous system, specifically the brain and spinal cord, rather than acting directly on muscle tissue itself. Chlorzoxazone is chemically an oxazol derivative. As a single-ingredient product, it delivers its effect through this specific compound alone, distinguishing it from combination relaxants that may include pain relievers.


What is the Purpose of Prolax and How is it Supplied?

The primary purpose of Prolax is to serve as an adjunctive treatment, or supplementary therapy, used for the relief of discomfort and stiffness associated with acute musculoskeletal conditions such as strains and sprains. Its role in managing muscle spasms supports its clinical use in interrupting the pain-spasm cycle. Chlorzoxazone is indicated as an adjunct to rest and physical therapy. This medication is intended to be used alongside non-drug treatments like physical rest to provide relief from acute muscle rigidity. Prolax is supplied in the form of an oral tablet for systemic administration, which provides a practical route for obtaining relief from muscle rigidity and improving mobility.

Regulatory References

  1. DailyMed Labeling
  2. DailyMed FDA Labeling

What side effects are possible with Prolax?

Possible Side Effects

Prolax (which may contain an active ingredient like Polyethylene Glycol 3350 or Lactulose, depending on the specific formulation) is generally well-tolerated, but like all medications, it can cause side effects. These are typically related to the gastrointestinal tract and are often mild and temporary.

Common Side Effects Less Common/Serious Side Effects
Bloating, gas, and flatulence Severe or persistent diarrhea (may lead to dehydration)
Mild stomach cramping or pain Rectal bleeding or blood in stool
Nausea or vomiting Signs of an allergic reaction (e.g., rash, hives, swelling of the face/throat, difficulty breathing)

If you experience any signs of a severe allergic reaction, rectal bleeding, or if stomach pain/cramping, diarrhea, or nausea worsen or do not resolve after stopping the medication, seek immediate medical attention.


Safety Information and Precautions

Do not use Prolax if you have a known or suspected bowel obstruction, intestinal blockage, stomach perforation, or an allergy to any of the product's ingredients. If you have a sudden change in bowel habits that lasts longer than two weeks, consult your healthcare provider before using a laxative.

Consult a healthcare professional before use if you have kidney disease, severe stomach pain, nausea, or vomiting. Prolonged or excessive use of most laxatives is generally discouraged, as it can lead to dependence or an electrolyte imbalance. It is recommended not to use this medication for more than seven consecutive days unless advised by a doctor. Pregnant or breastfeeding women should also consult their doctor before using Prolax to discuss the potential risks and benefits.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for an overdose of Prolax (Chlorzoxazone) describes specific clinical manifestations and mandates immediate emergency action.

Overdose may initially present with gastrointestinal disturbances such as nausea, vomiting, or diarrhea. Central nervous system effects are documented as drowsiness, dizziness, lightheadedness, or headache, accompanied by a marked loss of muscle tone and decreased or absent deep tendon reflexes. The sensorium is expected to remain intact.


Serious Outcomes and Emergency Action

The most serious outcomes documented in regulatory labeling involve respiratory depression, characterized by irregular respiration, and lowered blood pressure (hypotension). Immediate medical attention must be sought if any signs of overdose are observed, particularly those involving respiratory compromise.

Treatment is defined as entirely supportive, as no specific antidote is known for Chlorzoxazone. Official procedures described for management include gastric lavage or induced emesis followed by the administration of activated charcoal. If respirations are depressed, the use of oxygen and artificial respiration is required.

Therapeutic Uses of Prolax

What Prolax Treats: Main Uses and Benefits

Prolax is considered relevant for easing the painful, involuntary muscle spasm and subsequent stiffness that accompany acute musculoskeletal conditions like strains and sprains. The drug is applied in clinical settings that involve acute or unstable symptom patterns. It is commonly used to help with symptomatic manifestations across conditions presenting with significant muscular tension, including those related to low back pain and injuries involving muscle-related trauma.

The medication offers supportive therapeutic benefit by easing the severe muscular discomfort and rigidity that interfere with daily functioning during flare-ups. This supportive relief may assist with maintaining functional stability, which can help patients cope more steadily when engaging in necessary complementary treatments like rest and physical therapy, thereby contributing to easing the overall symptom load during the recovery phase.

“The medication is applied across domains where additional symptomatic support is needed during acute episodes of muscle tension and associated discomfort.”


Quick Fact: Relief for Acute Muscle Spasm

Aspect Description
Primary Focus Easing of involuntary muscle contraction and rigidity.
Context of Use Relevant when supportive symptom management is appropriate alongside rest and physical therapy.
Symptom Domains Acute musculoskeletal discomfort, stiffness, and pain.
Patient Benefit Helps maintain a sense of stability when symptoms are more noticeable.

Regulatory References

  1. Official FDA Labeling from DailyMed - NIH

Eligibility and Restrictions for Use

Who Can and Cannot Use Prolax (Chlorzoxazone)

The eligibility for Prolax is strictly defined by regulatory documents, distinguishing between populations that are permitted use, those requiring conditional use, and those for whom the drug is contraindicated.

Absolute Prohibitions and Restrictions

Classification Population or Condition
Contraindicated Patients with known intolerance or hypersensitivity to Chlorzoxazone
Required Discontinuation Individuals who develop signs or symptoms suggestive of liver dysfunction (e.g., elevated liver enzymes or jaundice)

Conditional Use and Establishment Status

Population Group Regulatory Status
Pediatric Use Safety and efficacy have not been established
Pregnancy Restricted/Conditional; safe use is not established with respect to fetal development
Lactation Status not established; it is not known if the drug passes into breast milk
Liver Compromise Use requires caution in patients with pre-existing liver disease

Use is generally permitted for adults as an adjunctive treatment for acute musculoskeletal conditions. The drug must be used with caution in individuals with a history of allergic drug reactions.

What should I know about interactions with other medicines?

The interaction profile for Prolax (Chlorzoxazone) is defined by its two primary regulatory domains: central nervous system (CNS) effects and metabolic clearance.


Pharmacodynamic Interactions

Co-administration with alcohol or any medicinal product classified as a Central Nervous System (CNS) depressant results in a formally documented additive CNS depressant effect. This interaction is noted in official warnings as a precautionary classification, reflecting the potential for combined effects from CNS-acting agents, including sedatives, hypnotics, and opioid analgesics. No specific drug-drug combinations are officially listed as prohibited or contraindicated beyond known intolerance to Chlorzoxazone itself.


Pharmacokinetic and Substance Interactions

The major pathway for Chlorzoxazone clearance is metabolism via the Cytochrome P450 2E1 (CYP2E1) enzyme. Substances that formally inhibit CYP2E1 activity are documented to increase the plasma concentration, AUC, and half-life of Chlorzoxazone, reflecting a reduced clearance rate.

Watercress is a specific herbal/food product that has been shown in regulatory-cited studies to inhibit CYP2E1, leading to increased systemic exposure. Official labeling also requires caution for use in patients with pre-existing liver disease, a constraint related to the drug’s elimination being dependent on healthy hepatic function. No mandatory administration timing rules for separation from other medicines are explicitly documented.

Mechanism of Action

How Prolax Works: Mechanism of Action

Prolax is a small molecule that primarily acts within domains involving specific receptor- or enzyme-mediated signaling pathways. Its action is focused on modulating particular mechanistic cascades that govern dysregulated biological processes at a cellular level.

Modulation of Specific Receptor Signaling

This domain describes Prolax's primary interaction with cell surface receptors, which are key targets in systems where specific transmitters or mediators dominate. Prolax acts as a ligand, either initiating or suppressing signaling sequences at these receptors. This targeted engagement modifies the kinetics of overactive signal transduction by adjusting the initial molecular steps of the cascade.

Influence on Intracellular Pathway Feedback

Prolax also engages mechanisms that regulate biological processes by modifying early molecular steps that shape systemic physiological outcomes. This influence involves modulating specific intracellular enzyme activity to affect feedback loops that govern pathway flux, resulting in downstream changes in homeostatic parameters within the targeted system.

Dosage and Administration Information

How Prolax is Used: Administration Guidelines

Prolax (Chlorzoxazone) is administered according to specific principles, ensuring its use is limited to an adjunct role alongside rest and physical therapy. The medicine is supplied as an oral tablet and must be taken by mouth.


Standard Adult Dosing and Frequency

The dosage of Prolax is individualized and initiated at a lower amount, then reduced as symptoms improve. The dosing range is based on the severity of the muscle spasm:

Regimen Aspect Instruction
Standard Dose 250 mg to 500 mg per dose.
Frequency 3 to 4 times daily.
Maximum Dose Should not exceed 750 mg per dose or 3000 mg total per day.

Administration Context and Course Duration

The duration of treatment is intended to be short-term for the management of acute musculoskeletal discomfort. As a procedural requirement, the dosage is reduced to the lowest effective level as soon as clinical improvement occurs.

Instruction Domain Guideline
With/Without Food May be taken with food or milk if gastrointestinal discomfort is a factor.
Preparation Tablets may be crushed and mixed with food, milk, or fruit juice.

Population-Specific Rules

The safety and effectiveness of Prolax have not been established for use in the pediatric population. Guidelines also note that Prolax should be used with caution in older adults, often advising the use of a lower starting dosage.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Prolax

Evidence for Use in Acute Muscle Spasm and Musculoskeletal Discomfort

Research exploring the effects of Prolax (Chlorzoxazone) mainly focuses on research exploring how outcomes related to physical discomfort change over time associated with acute conditions, such as short-term low back pain, muscle strains, and sprains. The core evidence stems from randomized controlled trials (RCTs) that was studied for adult patients experiencing acute, heightened symptom activity. These studies are designed to compare the effects of the medicine against either an inactive pill (placebo) or other treatments.

Within these trials, researchers primarily examined outcomes related to physical discomfort by monitoring changes in patient-reported outcomes describing perceived discomfort, such as pain scales. They also examined functional outcomes reflecting daily functioning or activity level, using tools to assess functional limitations. Studies report how symptoms evolved in the observed populations over short, defined time intervals. The evidence level is typically categorized as moderate, but consistency is a documented area of uncertainty.

How Prolax Was Evaluated Against Other Treatments in Trials

In addition to being studied against placebo, Prolax was studied for its symptomatic patterns when compared with other active approaches used for acute musculoskeletal conditions. Research explored short-term symptom changes in trials used in studies examining symptom intensity or variability, where researchers monitored how different treatment approaches were associated with outcomes capturing phases of heightened symptom activity.

Research highlights patterns of changes measured during the study period. Findings help contextualize how patients reported their experience when Prolax was studied for comparison with other approaches. Due to the differences in study design and follow-up, comparative evidence may be subject to limitations in direct interpretation.

Long-Term Outcomes and Follow-up Duration in Research

Consistent with its indication for acute conditions, the vast majority of clinical trials and systematic reviews explored short-term symptom changes over very limited follow-up durations, typically only for a few days to one or two weeks. Because the focus is on acute episodes, long-term effects are not fully established. There is limited information for long-term outcomes or outcomes related to chronic, ongoing conditions.

Research in Specific and Vulnerable Populations

Clinical trials for Prolax primarily focus on the general adult population. Consequently, data for certain groups remain insufficient. For instance, official regulatory summaries often point out that few data are available for both pediatric and geriatric (older adult) populations. This lack of specific research means that the results apply only to the populations studied in the primary clinical trials.

Key Studies & References

  1. Label: CHLORZOXAZONE tablet - DailyMed - NIH
  2. Efficacy of Metaxalone vs. Chlorzoxazone in Treating Musculoskeletal Pain: A Comparative Study

Frequently Asked Questions (FAQ)

Common questions about Prolax (FAQ)

Q: Is Prolax the same type of medicine as [similar common drug name]?

A: According to official product information, Prolax (Chlorzoxazone) is categorized as a skeletal muscle relaxant.

It is specifically classified as a centrally-acting agent, meaning its primary function involves modulation within the central nervous system.


Q: How quickly should Prolax start to work after I begin taking it?

A: Studies on Chlorzoxazone indicate that the medicine is rapidly absorbed into the body.

Blood levels can typically be detected within the first 30 minutes after taking the tablet, with peak concentrations often reached within about one to two hours.


Q: If I take Prolax, can I also take regular over-the-counter pain relievers?

A: The official warning notes that combining Prolax with other central nervous system (CNS) depressants can result in an additive depressant effect.

It is important to review all over-the-counter medicines with a healthcare professional to confirm they do not pose a risk of interaction.


Q: Is it okay to drive a car while taking Prolax?

A: Regulatory documents list side effects that may impair physical and mental abilities, such as drowsiness, dizziness, lightheadedness, and a general feeling of malaise.

Individuals should assess their personal reaction to the medication before driving or operating heavy machinery.


Q: Can elderly patients use Prolax safely?

A: Official information indicates that Prolax should be used with caution in older adults.

Caution is advised for older adults, and regulatory information notes they may be started on a reduced dosage under professional guidance.


Q: How long is Prolax usually taken for?

A: Prolax is indicated for the relief of discomfort related to acute, painful musculoskeletal conditions.

Consistent with this purpose, the medicine is intended and prescribed for short-term use only.


Q: What are the requirements for being eligible to use Prolax?

A: Prolax is a prescription-only drug indicated for use in adults.

Its official use is as an adjunct to rest and physical therapy for acute muscle discomfort, and it is contraindicated if a patient has a known intolerance to the drug.


Q: Can Prolax make existing stomach issues worse?

A: Gastrointestinal disturbances are listed as common side effects and can include nausea, vomiting, and diarrhea.

In rare cases, official warnings mention that gastrointestinal bleeding has been associated with the drug. Consulting with a healthcare professional is important if you have pre-existing stomach conditions or if symptoms worsen.


Q: How is the mechanism of action of Prolax described in simple terms?

A: Prolax is a centrally-acting agent and functions primarily within the central nervous system, specifically the spinal cord and lower brain areas.

It is thought to inhibit the specific nerve reflexes that are responsible for causing muscle spasm, and this action is believed to be linked to its general sedative properties.


Q: What are common patient misunderstandings about what Prolax is supposed to do?

A: Official information clarifies that Prolax is meant to be an adjunct, or supplementary treatment, used alongside measures like rest and physical therapy.

It is important to understand that the drug does not directly relax tense skeletal muscles in humans, but rather acts on the nerve signals.


Q: Can Prolax cause tiredness or drowsiness?

A: Yes, regulatory documents list tiredness and effects on alertness as possible side effects.

Specific effects reported by occasional patients include drowsiness, fatigue, and malaise (a general feeling of being unwell).


Q: Does Prolax interact with caffeine or coffee?

A: Studies cited by regulatory bodies indicate that Prolax can affect the body's process for eliminating caffeine.

This reduction in caffeine clearance could potentially increase the risk of experiencing caffeine-related side effects such as restlessness or insomnia.


Q: Are there any specific foods I should avoid while using Prolax?

A: The substance Watercress is specifically noted in regulatory-cited studies for its potential to inhibit the enzyme that breaks down Prolax.

Caution is advised regarding this substance. Any dietary restrictions should be reviewed with a healthcare professional.


Q: Is Prolax approved for use in children or teenagers?

A: The official product information states that the safety and efficacy of Prolax have not been established for use in the pediatric population.


Q: Can Prolax be used during pregnancy, based on regulatory information?

A: The safe use of Prolax has not been established regarding possible adverse effects on fetal development.

Regulatory documents emphasize that use in women of childbearing potential is advised only when the potential benefits are determined to outweigh the possible risks.


Q: Is Prolax known to affect kidney function?

A: According to the official product information, there is no evidence that Prolax causes damage to the kidneys.

While some patients may notice a harmless, clinically insignificant discoloration of their urine, the drug is not associated with direct renal injury.


Q: What is the risk of developing dependency on Prolax?

A: Prolax (Chlorzoxazone) is not scheduled under the Controlled Substances Act (CSA).

This means that it is not federally classified as a medicine with a potential for abuse or dependence.


Q: Why do some people say they feel restless after starting Prolax?

A: Official documents list over-stimulation as a central nervous system (CNS) side effect that may be noted by an occasional patient.

This side effect, along with others like dizziness or drowsiness, may contribute to feelings of restlessness.


Q: What kind of monitoring or follow-up is generally expected while taking Prolax?

A: Regulatory information highlights the importance of monitoring for early signs of liver injury (hepatotoxicity) such as fever or rash.

If these symptoms occur, the medication must be discontinued as directed by a healthcare professional.


Q: Can men and women use Prolax for the same conditions?

A: Prolax is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults generally.

There is no differentiation by sex in the primary official indication for the drug.


Q: What should I do if I notice a change in my sleep patterns while on Prolax?

A: Prolax affects the central nervous system, and side effects listed include both drowsiness and over-stimulation.

If changes in sleep patterns occur, it is important to consult a healthcare professional.


Q: Why do official materials refer to Prolax by a chemical name sometimes?

A: Official documentation, such as the drug label, includes the chemical name to clearly identify the active compound.

This specific name, 5-Chloro-2-benzoxazolinone, is the precise chemical identification of the active ingredient, Chlorzoxazone.


Q: Are there known interactions between Prolax and herbal supplements?

A: Prolax is metabolized (broken down) by a specific enzyme called CYP2E1.

Substances that inhibit this enzyme, such as the herbal/food product Watercress, can increase drug exposure. Caution is advised for use with herbal products generally.


Q: What are the general expectations about the success rate of Prolax treatment?

A: Clinical trials primarily focused on measuring changes in patient-reported outcomes describing perceived discomfort and functional limitations.

While the evidence level is generally categorized as moderate, official summaries note that consistency of findings across studies is a documented area of uncertainty.


Q: What are the key differences between the purpose of Prolax and a vitamin supplement?

A: Prolax is a prescription-only, centrally-acting skeletal muscle relaxant used for acute musculoskeletal discomfort.

In contrast, vitamin supplements are non-prescription dietary products used to provide nutrients and are not indicated as pharmaceutical treatments for medical conditions.


Q: What is the official safety classification of Prolax?

A: The official classification for Chlorzoxazone is Prescription Only (Rx) medicine.

It is also officially noted as being not subject to control under the Controlled Substances Act (CSA).


Q: How soon after stopping Prolax can I start taking another related medicine?

A: Official information indicates that Prolax is rapidly metabolized and subsequently excreted from the body.

Specific waiting times before starting another medication should be reviewed with a healthcare professional.

How should Prolax be stored and disposed of?

How to Store and Dispose of Prolax (Chlorzoxazone)

The storage and disposal of Prolax tablets (Chlorzoxazone) must strictly follow official governmental regulatory requirements to maintain product integrity and ensure safety.

Storage Conditions

The medication must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). The product must be protected from freezing, excessive heat, moisture, and direct light. Prolax must be kept in a tightly closed container and stored out of the reach of children.

Disposal Instructions

Outdated or unused medicine must be disposed of safely. Prolax is not on the list of medicines recommended for flushing. The preferred method is using a drug take-back program. If unavailable, unused tablets can be mixed with an undesirable substance, sealed in a container, and disposed of in the household trash; personal information must be scratched from the label before discarding the container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prolax found in:

A-Z Index: